Sofpironium bromide, sold under the brand name Ecclock among others, is a
medication used to treat
hyperhidrosis (excessive sweating).[1] It is an anticholinergic and is applied to the skin.[1]
^Huang F, Brown CE, Wu WM, Juhász A, Ji F, Bodor N (October 2003). "Design, pharmacokinetic, and pharmacodynamic evaluation of a new class of soft anticholinergics". Pharmaceutical Research. 20 (10): 1681–9.
doi:
10.1023/a:1026160023030.
PMID14620526.
S2CID20657068.
^World Health Organization (2017). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 77". WHO Drug Information. 31 (1).
hdl:10665/330984.
Clinical trial number NCT03836287 for "Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) (CardiganI)" at
ClinicalTrials.gov
Clinical trial number NCT03948646 for "Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) (CARDIGANII)" at
ClinicalTrials.gov
Sofpironium bromide, sold under the brand name Ecclock among others, is a
medication used to treat
hyperhidrosis (excessive sweating).[1] It is an anticholinergic and is applied to the skin.[1]
^Huang F, Brown CE, Wu WM, Juhász A, Ji F, Bodor N (October 2003). "Design, pharmacokinetic, and pharmacodynamic evaluation of a new class of soft anticholinergics". Pharmaceutical Research. 20 (10): 1681–9.
doi:
10.1023/a:1026160023030.
PMID14620526.
S2CID20657068.
^World Health Organization (2017). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 77". WHO Drug Information. 31 (1).
hdl:10665/330984.
Clinical trial number NCT03836287 for "Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301) (CardiganI)" at
ClinicalTrials.gov
Clinical trial number NCT03948646 for "Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302) (CARDIGANII)" at
ClinicalTrials.gov